Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Snips Ribbon on New US Headquarters

NEW YORK, Jan. 11 - Qiagen Sciences has opened its new manufacturing complex in biotech-rich Germantown, Md., the company announced on Friday.

 

The 200,000-square-foot facility, which becomes Qiagen's new North American headquarters for manufacturing, production, and research and development, will employ 100 R&D personnel and more than 200 manufacturing staff to develop and process DNA separation and purification products.

 

Manufacturing activities will start by the end of February, the company said. Qiagen is based in Venlo, the Netherlands.

 

Qiagen generates approximately 60 percent of its consolidated revenues in the United States, said Peer M. Schatz, CFO for Qiagen. The new facility "should have a positive impact on the company's exposure to currency fluctuations, as well as enhance logistics," he added.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.